Guerra Stefano
Arizona Respiratory Center and Department of Medicine, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Curr Opin Pulm Med. 2005 Jan;11(1):7-13. doi: 10.1097/01.mcp.0000146780.33963.bf.
Asthma and chronic obstructive pulmonary disease (COPD) are both defined by the presence of airflow obstruction, but they present distinguishing differences in terms of both risk factors and clinical phenotypes. Yet it is quite common in the clinical setting to observe patients with asthma showing COPD-like phenotypes, and vice versa, making it a priority to search for optimal prevention, treatment, and management strategies for these cases of coexisting lung obstructive diseases.
Recent studies have provided further evidence of strong epidemiologic and clinical links between asthma and COPD. Adult subjects with active asthma are as much as 12 times more likely to acquire COPD over time than subjects with no active asthma. Signs identifying patients with asthma predisposed to developing COPD may already be present at the early stages of the disease, a finding with potential implications for prevention of COPD. In addition to spirometry and other pulmonary function tests (such as measurements of residual volume and diffusing capacity of the lung for carbon monoxide), recent evidence suggests that the assessment of type and degree of airway remodeling and the evaluation of inflammatory markers might prove useful in the future to characterize phenotypically patients with coexisting asthma and COPD.
The nature of the association between asthma and COPD remains unclear and open to discussion. Further research is required to develop effective management algorithms for patients with multiple obstructive lung diseases, determine to what extent early treatment and optimal management of asthma may protect against progression into COPD, and identify genetic markers of individual susceptibility to specific lung disease phenotypes and pharmacologic treatments.
哮喘和慢性阻塞性肺疾病(COPD)均由气流受限定义,但它们在危险因素和临床表型方面存在显著差异。然而,在临床环境中,哮喘患者表现出COPD样表型以及COPD患者表现出哮喘样表型的情况相当常见,因此为这些并存的肺部阻塞性疾病寻找最佳的预防、治疗和管理策略成为当务之急。
近期研究进一步证明了哮喘与COPD之间存在密切的流行病学和临床联系。随着时间推移,患有活动性哮喘的成年受试者患COPD的可能性比无活动性哮喘的受试者高12倍。在疾病早期阶段可能就已出现识别易发展为COPD的哮喘患者的体征,这一发现对COPD的预防具有潜在意义。除了肺量计检查和其他肺功能测试(如残气量和肺一氧化碳弥散量测量)外,近期证据表明,评估气道重塑的类型和程度以及炎症标志物可能在未来有助于对并存哮喘和COPD的患者进行表型特征描述。
哮喘与COPD之间关联的本质仍不明确,有待进一步探讨。需要开展进一步研究,以制定针对多种阻塞性肺疾病患者的有效管理方案,确定哮喘的早期治疗和优化管理在多大程度上可预防发展为COPD,并识别个体对特定肺部疾病表型和药物治疗易感性的遗传标志物。